-- Biocon (NSE:BIOCON, BOM:532523) consolidated attributable profit declined sharply in the fiscal fourth quarter to 1.26 billion Indian rupees from 3.45 billion rupees a year ago, according to an Indian bourse filing on Thursday by the pharmaceutical company.
Earnings per share in the quarter ended March 31 slipped to 0.79 rupees compared with the year-ago figure of 2.87 rupees.
Revenue from operations in fiscal Q4, however, increased year on year to 45.2 billion rupees from 44.2 billion rupees.
The company's board recommended a final dividend of 0.50 rupees per share for the financial year ended March 31. The proposed dividend is payable on Aug.31 to shareholders of record on July 3, the filing said.